NCT06463860Completed
Multi-Center Study to Evaluate the Performance of DermDx for Primary Care Physicians in the Detection of Skin Cancers
Retrospective, Multi-Center Study to Evaluate the Performance of DermDx as an Adjunctive Tool for Primary Care Physicians in the Detection of Skin Cancers
Source: ClinicalTrials.gov · Last updated 19 Dec 2024
Brief summary (registry, in English)
The proposed study is a pivotal, multi-center retrospective reader study designed to determine whether the use of DermDx as a concurrent reading aid improves the performance of primary care physicians (PCPs) in diagnosing skin cancers.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 81 (actual)
- First submitted
- 11 Jun 2024
- Start date
- 12 Jun 2024
- Primary completion date
- 27 Nov 2024
- Lead sponsor
- MetaOptima Technology Inc.
- Diseases
- Childhood cancers
- NCT number
- NCT06463860
What you commit to
- Study type: Observational
- Participants enrolled: 81
- From 12 Jun 2024 to the primary completion date, 27 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subjects not meeting inclusion criteria.
Who the study is looking for
- The subjects must be Primary Care Physicians who are board certified in family medicine or internal medicine.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Remote Coordinator of this site? Confirm its status | North Augusta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.